IUDs Becoming More Popular than Birth Control Pills

Intrauterine devices (IUDs) have been used by more women compared to birth control pills, according to a statistics. One of the popular brands of the IUD is Mirena, a small, T-shaped and flexible device which is inserted into the uterus. It is believed to be 99.9 percent effective in preventing pregnancies but it seems to be a controversial contraceptive which results to some lawsuits.

Studies reveal that IUD is 20 times more effective than other birth control methods like pills, patches and vaginal rings. Birth control pills, the method of choice for 28 percent of U.S. women, are the most commonly used form of reversible contraception, but their effectiveness depends on consistent daily use. Surveys have reported failure rates with the Pill similar to those seen in the current study. Patches and rings require less attentiveness than pills, but they still leave room for human error. The birth control patch needs to be changed weekly, while the vaginal ring needs to be changed once a month.

Women choose to use IUDs because of its long-term effectiveness in preventing pregnancy, plus it is fuss-free to use, unlike pills which you have to remember to take it everyday. A woman may use IUD as contraceptive for up to five years, but if you decide to get pregnant again, the IUD may be removed by the help of your doctor. The main advantage of IUD is that it works immediately; it requires no maintenance and is a one-time cost, allow you to have sex immediately.

However, these birth control methods are associated with various health complications. For instance, IUD is believed to cause infection and fertility problems. In one out of 1,000 women, the IUD may potentially get stuck in or puncture (perforate) the uterus. Although perforation cases are rare, it almost always occurs during insertion. The IUD may need to be removed if the uterus has been perforated because it may damage the uterus and its nearby organs.

If you are a woman who is interested in Mirena or is having problems with Mirena, you may refer to Mirena IUD Side Effects, which has more substantial information regarding this matter.

References:

• abcnews.go.com/Health/iuds-effective-pill-study/story?id=16415959#.UWhYQqKmiAg
• articles.latimes.com/2012/feb/28/health/la-he-contraception-insurance-20120228
• foxnews.com/health/2012/08/02/more-us-women-choosing-iuds-for-birth-control/
• answers.yahoo.com/question/index?qid=20100612122552AAhj6Fh

Panel to Decide on Mirena IUD Lawsuit Consolidation, Rottenstein Law Group Reports

On March 21 a judicial panel was expected to meet to decide on the consolidation of pretrial proceedings of Mirena lawsuits in federal courts nationwide.* The Rottenstein Law Group, a Mirena IUD law firm, maintains a website that features Mirena news, in addition to Mirena IUD lawsuit information.

 

The United States Judicial Panel on Multidistrict Litigation in San Diego, Calif., is considering the consolidation (also known as a “multidistrict litigation”) as a way to streamline pretrial processes from multiple federal courts around the country into a single federal court under one presiding judge, according to court records (In re: Mirena IUD Products Liability Litigation, MDL No. 2434 (JPML)). The Mirena IUD, manufactured by Bayer, is an intrauterine device that slowly releases a hormone over five years to prevent pregnancy. It has been alleged to cause serious adverse side effects, such as device migration, device embedment and pain and discomfort.

 

“The MDL would allow the plaintiffs in the existing federal cases—and additional future claimants—to more quickly get their day in court,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, which currently represents clients in Mirena lawsuits nationwide. “Mirena recipients trusted that Bayer’s IUD was a safe contraceptive alternative. If the evidence of eventual trials suggests Bayer violated that trust, then the company should be held accountable.”

 

Read full story at PRWeb.com: Panel to Decide on Mirena IUD Lawsuit Consolidation, Rottenstein Law Group Reports

Mirena IUD Lawsuit Update: The Rottenstein Law Group Responds to Report of Lawsuits’ Effect on Bayer’s Recent Stock Performance

NEW YORK, Feb. 12, 2013 /PRNewswire/ — The Rottenstein Law Group acknowledges a Bloomberg report about German drug manufacturer Bayer’s recent stock losses, which the story attributes to a Mirena lawsuit.

The company saw a 2.8 percent loss following an American woman’s lawsuit (Prendergast v. Bayer Pharmaceuticals Corp., 13-00450, U.S. District Court for the Eastern District of Pennsylvania) against Bayer, according to Bloomberg.* She alleges that the company failed to warn of the risks associated with the Mirena hormonal intrauterine device, such as the risk of ectopic pregnancy and the possibility of device embedment and migration.** As of Feb. 11th, the company stock price slump has persisted.

Rochelle Rottenstein , principal of the Rottenstein Law Group, said she has heard from many women who have discussed similar alleged side effects and risks associated with the Mirena IUD. The Rottenstein Law Group represents clients in Mirena lawsuits.

Read full story at PRNewswire.com: Mirena IUD Lawsuit Update: The Rottenstein Law Group Responds to Report of Lawsuits’ Effect on Bayer’s Recent Stock Performance